期刊文献+

生存素和血管生成素2的表达在乳腺癌淋巴转移中的作用 被引量:1

Expressions of survivin and Ang2 and their effects on lymphatic metastasis of breast carcinoma
在线阅读 下载PDF
导出
摘要 目的探讨Survivin和Ang2在人乳腺癌组织中的表达及其在淋巴转移中的作用。方法 60例乳腺癌组织,应用免疫组织化学S-P法检测Survivin和Ang2在乳腺癌组织中的表达情况,RT-PCR检测Survivin及VEGF-CmRNA的表达。结果 60例乳腺癌组织中Survivin和Ang2的表达阳性率分别为85.0%和73.3%,Survivin阳性表达组中Ang2的表达为74.5%(35/51),Survivin阴性表达组中Ang2的表达为66.7%(6/9),经直线相关分析,两者在乳腺癌中的相关系数r=0.32,呈正相关,P=0.01。结论 Survivin和Ang2在乳腺癌组织中过表达,呈正相关。Survivin表达上调可能促使Ang2的过表达,诱导乳腺癌淋巴管生成,从而导致乳腺癌淋巴转移的发生。 Objective To investigate survivin and Ang2 expressions in breast carcinoma tissue and its effect in lymphatic metastasis.Methods 60 cases of breast carcinoma,Immunohistochemical SP method was adopted in detecting survivin and Ang2 expressions in breast carcinoma tissue,RT-PCR for detecting survivin and VEGF-C mRNA expressions.Results Positive rate of survivin and Ang2 was 85.0% and 73.3% respectively in 60 cases of breast carcinoma,positive rate of Ang2 was 74.5%(35/51) in the positive Survivin expression group,while that in negative Survivin expression Group was 66.7%(6/9) respectively,with undergoing correlation analysis,both sides were positive correlated with each other in breast carcinoma(r=0.32,p=0.001).Conclusion The expressions of survivin and Ang2 were high in breast carcinoma,which were positively correlated with each other.Up-regulation in survivin expression may urge hyper-expression of Ang2,accordingly to promote tumor lymph angiogenesis and metastasis of tumor lymph node.
作者 李湘奇
出处 《中国实验诊断学》 2012年第11期2014-2017,共4页 Chinese Journal of Laboratory Diagnosis
基金 山东省自然基金项目(ZR2009CM039) 山东省医药卫生科技发展计划(2011HW084)
关键词 乳腺癌 淋巴转移 生存素 血管生成素2 breast cancer lymphatic metastasis survivin Ang2
  • 相关文献

参考文献16

  • 1Yonemura Y,Endou Y,Tabachi K,et al. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40[J]. Hum Pathol,2006,37(9):1193.
  • 2AhieriDC. Survivin, cancernetworks and pathway-directed drug discovery[J]. NatRevCancer, 2008,8 (1) : 61.
  • 3陈秀慧,曲军英.Ang-2及VEGF在早期宫颈癌中的表达及与血管及淋巴管密度的相关性[J].福建医药杂志,2011,33(1):4-7. 被引量:7
  • 4World Health Organization. The World Health Organization his tological typing of breast tumors-second edition[J]. Am J Clin Patbol 1982,78 : 806.
  • 5Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed[M]. New York : Springer, 2010,347.
  • 6Chau NM, Ashcroft M. Akt2:a role in breast cancer metasta-sis[J]. Breast Cancer Res,2004,6(1):55.
  • 7杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:280
  • 8Johnson ME, Howerth EW. survivin: A bifunctional Inhibitor of apoptosis protein[J]. VetPathol, 2004,41 ( 6 ) : 599.
  • 9TanakaK, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res,2000,6(1) :127.
  • 10Tan G, Cioc A M, Perez Montie D, et al. Microvascular density dose not correlate with histopathology and outcome in neuroendoerine tumors of the paneereas[J]. Appl Immunohistochem Mol Morphol,2004,12(1) :31.

二级参考文献35

共引文献293

同被引文献29

  • 1Althuis MD, Dozier JM, Anderson WF, et al. Global trends in breastcancer incidence and mortality 1973-1997. Int J Epidemiol, 2005, 34:405-412.
  • 2Martelli AM, Faenza I, Billi AM, et al.Intranuclear3 phosphoinositidemetabolism and Akt signaling: new mechanisms for tumorigenesis andprotection against apoptosis? Cell Signal, 2006, 18: 1101-1107.
  • 3Murthy SS, Tosolini A, Taguchi T, et al. Mapping of AKT3, encoding amember of the Akt/protein kinase B family, to human and rodentchromosomes by fluorescence in situ hybridization. Cell Genet, 2000,88: 38-40.
  • 4Testa JR, Bellacosa. AKT piays a central role in tumorgenesis.ProcNatl Acad Sci USA, 2001,98: 10983-10985.
  • 5Nelson PA, Powers JN, Estridge TD, et al. Serological analysis ofpatients treated with a new surgical hemostat containing bovineproteins and autologous plasma. J Biomed Mater Res, 2001, 58: 710-719.
  • 6Yoeli-Lerner M, Toker A. Akt/PKB signaling in cancer: a function incell motility and invasion. Cell Cycle, 2006, 5: 603-605.
  • 7Itoh N, Semha S, Ito M, et al. Phosphorylation of Akt/PKB is requiredfor suppression of cancer cell apoptosis and tumor progression inhuman colorectal carcinoma. Cancer, 2002, 94: 3127-3134.
  • 8Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expressionis linked to elevated phosphorylated Akt levels, hut not associated withp27 and cyclin D1 expression, in primary epithelial ovariancarcinomas. Am J Pathol, 2001, 158: 2097-2106.
  • 9Sun M, Wang G, Paciga JE, et al. AKT1/PKBalpha kinase isfrequently elevated in human cancers and its constitutive activation isrequired for oncogenic transformation in NIH3T3 cells. Am J Pathol,2001, 159:431-437.
  • 10Nam SY, Lee HS, Jung GA, et al. Akt/PKB activation in gastriccarcinomas correlates with clinicopathologic variables and prognosis.APMIS, 2003, 111: 1105-1113.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部